Blue Cross & Blue Shield of MississippiCommercial · Coverage · Medical Policy · MS · Infectious Disease, Critical Care, Pulmonology +1 moreMedium impact
State and School Employees' Health Insurance Plan - Recarbrio (imipenem-cliastatin-relebactam)
Act
immediately
Effective date
Not stated in the notice
Identified
Jun 20, 2026
Summary
Mississippi's State and School Employees' Health Insurance Plan has updated their policy to consider Recarbrio (imipenem-cilastatin-relebactam) not medically necessary for all approved indications, including hospital-acquired pneumonia and complicated infections. The drug is only covered when patients have limited or no alternative treatment options for certain conditions.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.
01Billing team must update system to flag HCPCS code J0742 (Recarbrio injection) as requiring documentation of limited or no alternative treatment options for complicated UTI and intra-abdominal infections.
02For hospital-acquired pneumonia and ventilator-associated pneumonia, claims will likely be denied as not medically necessary.
03Providers must document exhaustion of covered alternatives before using Recarbrio.
Codes mentioned
J0742
Original notice
State and School Employees' Health Insurance Plan - Recarbrio (imipenem-cliastatin-relebactam)
bcbsms.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.